Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $45.37 | $9.47 | 378.89% | 283.56x | 44.92x | 20.04x | 32.05x | 1.89x | -$40.56M | -0.61% | $222.36M | 1.53 | $7.20B | 144.85 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $8.20 | $3.27 | 150.56% | 205.00x | 17.60x | 4.99x | 2.98x | 0.96x | $44.11M | 3.76% | $377.48M | 2.64 | $1.12B | 35.37 | ||
| CORT | CORCEPT THERAPEUTICS INC | $71.48 | $33.13 | 115.77% | 52.95x | 40.56x | 10.93x | 11.10x | 1.00x | $195.90M | 2.66% | $679.59M | 6.58 | $7.42B | 54.24 | ||
| KRYS | KRYSTAL BIOTECH INC | $165.69 | $83.29 | 98.93% | 53.11x | 23.66x | 16.31x | 5.04x | 0.90x | $119.18M | 2.52% | $946.38M | 33.10 | $4.44B | 43.45 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $7.56 | $1.89 | 300.22% | 68.73x | 61.31x | 5.76x | 12.75x | 2.12x | $11.97M | 2.09% | $46.09M | 0.61 | $545.78M | 52.79 | ||
| SPRY | ARS PHARMACEUTICALS INC | $14.16 | $2.07 | 583.76% | 177.00x | -11.05x | 15.39x | 5.41x | 3.12x | $12.99M | 0.95% | $256.80M | 2.65 | $1.41B | 168.32 | ||
| GYRE | GYRE THERAPEUTICS INC | $9.34 | $7.40 | 26.19% | 66.71x | 22.24x | 7.51x | 13.81x | 0.50x | -$5.56M | -0.70% | $63.32M | 0.74 | $864.13M | 44.03 | ||
| ARGX | ARGENX SE | $639.90 | $219.44 | 191.60% | 42.29x | 50.70x | 8,100.00x | 6.51x | 1.70x | -$91.90M | -0.24% | $5.98B | 99.85 | $37.29B | 326.23 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.27 | $18.40 | 31.90% | 17.59x | 11.61x | 5.85x | 4.05x | 0.81x | $239.25M | 8.32% | $727.63M | 6.14 | $2.43B | 9.57 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $29.86 | $37.84 | -21.09% | 11.66x | 10.35x | 2.38x | 2.60x | 0.45x | $218.67M | 12.87% | $659.16M | 11.59 | $1.44B | 6.16 | ||
| VCEL | VERICEL CORP | $37.92 | $7.12 | 432.68% | 180.57x | 111.53x | 7.81x | 6.49x | 2.28x | -$5.81M | -0.31% | $291.97M | 5.98 | $1.91B | 81.99 | ||
| EXEL | EXELIXIS INC | $38.89 | $24.75 | 57.12% | 21.61x | 19.04x | 5.20x | 4.85x | 0.95x | $671.54M | 5.95% | $2.24B | 7.74 | $10.86B | 14.71 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $62.78 | $87.40 | -28.17% | 25.42x | 11.14x | 3.14x | 3.99x | 0.31x | -$342.74M | -5.74% | $1.53B | 16.07 | $6.32B | 20.08 | ||
| HALO | HALOZYME THERAPEUTICS INC | $60.03 | $57.14 | 5.06% | 17.15x | 12.37x | 7.50x | 20.32x | 0.57x | $468.37M | 6.15% | $363.82M | 2.87 | $8.78B | 13.38 | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $18.72 | $16.71 | 12.03% | 18.91x | 15.78x | 1.84x | 101.70x | 0.60x | $31.17M | 9.47% | $3.29M | 0.19 | $337.61M | 11.84 | ||
| RPRX | ROYALTY PHARMA PLC | $32.48 | $49.31 | -34.14% | 16.92x | 7.32x | 6.43x | 1.81x | 0.30x | $2.69B | 18.51% | $10.34B | 23.08 | $25.41B | 23.43 | ||
| NVO | NOVO NORDISK A S | $65.60 | $39.97 | 64.13% | 20.72x | 17.04x | 7.22x | 14.62x | 1.06x | $10.31B | 3.52% | $20.04B | 4.49 | $305.07B | 14.93 | ||
| ADMA | ADMA BIOLOGICS INC | $23.27 | $7.83 | 197.37% | 27.38x | 32.77x | 12.72x | 15.84x | 2.72x | $110.45M | 2.04% | $349.02M | 1.50 | $5.50B | 37.24 | ||
| INCY | INCYTE CORP | $62.03 | $22.07 | 181.03% | 213.90x | 13.04x | 2.72x | 3.27x | 1.08x | $302.71M | 2.52% | $3.67B | 18.93 | $10.10B | 24.83 | ||
| MDXG | MIMEDX GROUP INC | $6.32 | $5.06 | 24.83% | 23.41x | 21.79x | 2.64x | 4.60x | 0.64x | $64.60M | 6.95% | $202.78M | 1.38 | $845.70M | 13.36 | ||
| MNKD | MANNKIND CORP | $4.95 | $2.21 | 123.49% | 49.50x | 28.56x | 4.76x | -19.07x | 1.07x | $32.82M | 2.42% | -$78.82M | -0.29 | $1.74B | 22.50 | ||
| VCYT | VERACYTE INC | $29.71 | $9.14 | 225.13% | 92.84x | 37.49x | 5.10x | 1.97x | 1.45x | $63.81M | 2.81% | $1.18B | 15.38 | $2.13B | 39.25 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $62.71 | $38.55 | 62.68% | 27.87x | 18.17x | 4.18x | 2.11x | 0.86x | $497.42M | 4.17% | $5.66B | 29.78 | $11.62B | 17.85 | ||
| GNFT | GENFIT SA | $4.08 | $1.14 | 258.74% | 120.00x | -7.10x | 2.53x | 2.59x | 1.54x | $16.65M | 8.16% | $78.66M | 1.57 | $181.65M | 19.16 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $117.18 | $152.85 | -23.33% | 12.93x | 5.71x | 1.78x | 1.74x | 0.41x | $1.36B | 18.74% | $4.09B | 66.20 | $10.85B | 7.94 | ||
| TECH | BIO-TECHNE CORP | $49.63 | $18.38 | 170.00% | 49.63x | 29.93x | 6.57x | 3.77x | 1.39x | $254.30M | 3.23% | $2.08B | 13.12 | $8.06B | 25.83 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $14.57 | $9.99 | 45.83% | 10.64x | 23.97x | 2.52x | 3.32x | 2.25x | $157.20M | 6.51% | $732.79M | 4.42 | $2.14B | 7.83 | ||
| GMAB | GENMAB A | $20.93 | $17.39 | 20.37% | 12.26x | 14.39x | 4.61x | 2.70x | 0.96x | $1.04B | 7.53% | $5.13B | 7.74 | $12.62B | 7.82 | ||
| UTHR | UNITED THERAPEUTICS CORP | $293.85 | $162.54 | 80.79% | 10.85x | 10.87x | 4.41x | 1.95x | 9.77x | $1.13B | 8.55% | $6.81B | 151.61 | $11.55B | 6.89 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $590.00 | $246.84 | 139.03% | 14.12x | 18.70x | 4.47x | 2.17x | 16.59x | $3.12B | 4.96% | $29.39B | 275.42 | $63.31B | 11.45 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.